@article{16d77f0f72f147c39c6e5c52e896a347,
title = "Meningeal lymphatic dysfunction exacerbates traumatic brain injury pathogenesis",
abstract = "Traumatic brain injury (TBI) is a leading global cause of death and disability. Here we demonstrate in an experimental mouse model of TBI that mild forms of brain trauma cause severe deficits in meningeal lymphatic drainage that begin within hours and last out to at least one month post-injury. To investigate a mechanism underlying impaired lymphatic function in TBI, we examined how increased intracranial pressure (ICP) influences the meningeal lymphatics. We demonstrate that increased ICP can contribute to meningeal lymphatic dysfunction. Moreover, we show that pre-existing lymphatic dysfunction before TBI leads to increased neuroinflammation and negative cognitive outcomes. Finally, we report that rejuvenation of meningeal lymphatic drainage function in aged mice can ameliorate TBI-induced gliosis. These findings provide insights into both the causes and consequences of meningeal lymphatic dysfunction in TBI and suggest that therapeutics targeting the meningeal lymphatic system may offer strategies to treat TBI.",
author = "Bolte, {Ashley C.} and Dutta, {Arun B.} and Hurt, {Mariah E.} and Igor Smirnov and Kovacs, {Michael A.} and McKee, {Celia A.} and Ennerfelt, {Hannah E.} and Daniel Shapiro and Nguyen, {Bao H.} and Frost, {Elizabeth L.} and Lammert, {Catherine R.} and Jonathan Kipnis and Lukens, {John R.}",
note = "Funding Information: We thank members of the Lukens lab and the Center for Brain Immunology and Glia (BIG) for valuable discussions. Graphical illustrations in Figs. 1a, e, 6h, and Supplementary Fig. 5a were made using BioRender (https://biorender.com/). This work was supported by The National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01NS106383; awarded to J.R.L.), The Alzheimer{\textquoteright}s Association (AARG-18-566113; awarded to J.R.L.), The Owens Family Foundation (Awarded to J.R.L.), and The University of Virginia Research and Development Award (Awarded to J.R.L.). A.C.B., A.B.D., and M.A.K. were supported by a Medical Scientist Training Program Grant (5T32GM007267-38). A.C.B. and M.A.K. were supported by an Immunology Training Grant (5T32AI007496-25). A.C.B. was supported by a Wagner Fellowship. A.B.D. was supported by a Biomedical Data Sciences Training Grant (T32LM012416). H.E.E. was supported by a Cell and Molecular Biology Training Grant (T32GM008136). B.H.N. was supported by an R35 grant (5R35GM128635-02). C.R.L. was supported by a NIH National Institute of General Medical Sciences predoctoral training grant (3T32GM008328) and a Wagner Fellowship. E.L.F. was supported by a National Multiple Sclerosis Foundation Postdoctoral Fellowship (FG-1707-28590). Publisher Copyright: {\textcopyright} 2020, The Author(s).",
year = "2020",
month = dec,
day = "1",
doi = "10.1038/s41467-020-18113-4",
language = "English",
volume = "11",
journal = "Nature Communications",
issn = "2041-1723",
number = "1",
}